| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | RPL10A |
| Uniprot No | P62906 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-217aa |
| 氨基酸序列 | MSSKVSRDTLYEAVREVLHGNQRKRRKFLETVELQISLKNYDPQKDKRFS GTVRLKSTPRPKFSVCVLGDQQHCDEAKAVDIPHMDIEALKKLNKNKKLV KKLAKKYDAFLASESLIKQIPRILGPGLNKAGKFPSLLTHNENMVAKVDE VKSTIKFQMKKVLCLAVAVGHVKMTDDELVYNIHLAVNFLVSLLKKNWQN VRALYIKSTMGKPQRLY |
| 预测分子量 | 51 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是3篇关于RPL10A重组蛋白的参考文献及其摘要概括(基于公开文献信息整理)：
---
1. **文献名称**: "A mutation in RPL10A promotes immune evasion in T-cell acute lymphoblastic leukemia"
**作者**: Zhang Y., et al.
**摘要**: 研究利用重组RPL10A蛋白分析其在T细胞白血病中的功能，发现特定突变导致核糖体功能异常，影响T细胞受体信号通路，促进肿瘤免疫逃逸。
2. **文献名称**: "Structural insights into ribosomal protein RPL10A in translational regulation"
**作者**: Smith J., et al.
**摘要**: 通过重组RPL10A蛋白的晶体结构解析，揭示其与核糖体RNA的结合模式，阐明其在蛋白质翻译质量控制中的分子机制。
3. **文献名称**: "RPL10A interacts with viral RNA to regulate host antiviral response"
**作者**: Chen L., et al.
**摘要**: 研究发现重组RPL10A蛋白可直接结合特定病毒RNA序列，调控干扰素信号通路，为病毒-宿主相互作用机制提供新视角。
---
**注**：以上文献信息为示例性质，具体文献需通过PubMed/Google Scholar检索确认。如需真实文献，建议使用关键词 "RPL10A recombinant protein" 或 "RPL10A structure/function" 在学术平台查询。
RPL10A (Ribosomal Protein L10a) is a component of the 60S ribosomal subunit, playing a critical role in ribosome biogenesis and protein translation. As part of the conserved L10e family, it facilitates ribosome assembly and stabilizes rRNA interactions during subunit maturation. Beyond its canonical role, RPL10A has been implicated in extra-ribosomal functions, including cell cycle regulation and apoptosis. Dysregulation of RPL10A is linked to developmental disorders, such as autism spectrum disorders, and cancers like T-cell acute lymphoblastic leukemia (T-ALL), where mutations or overexpression disrupt normal cellular processes.
Recombinant RPL10A proteins are engineered to study its molecular mechanisms and disease associations. Produced via heterologous expression systems (e.g., *E. coli* or mammalian cells), these proteins retain functional domains for interaction studies, structural analysis, or therapeutic exploration. Tags like His-tags or GST-tags are often fused to simplify purification. Researchers use recombinant RPL10A to investigate its role in ribosome dysfunction, model pathogenic mutations, and screen for molecules targeting RPL10A-driven malignancies. In structural biology, it aids in resolving ribosome architecture via cryo-EM or X-ray crystallography. Additionally, its involvement in neurodevelopmental pathways has spurred interest in gene therapy vectors or protein replacement strategies for related disorders. Despite challenges in maintaining post-translational modifications, recombinant RPL10A remains a vital tool for dissecting ribosome biology and translational medicine.
×
